What Should Be Done To Tackle Ghostwriting in the Medical Literature?

1. AngellM

2004

The truth about the drug companies: How they deceive us and what to do about it

New York

Random House

336

2. KassirerJP

2005

On the take: How medicine's complicity with big business can endanger your health

Oxford

Oxford University Press

272

3. SmithR

2006

The trouble with medical journals

London

Royal Society of Medicine Press

292

4. World Association of Medical Editors

2005

Ghost writing initiated by commercial companies.

Available: http://www.wame.org/resources/policies#ghost. Accessed 29 December 2008

5. GøtzschePCHróbjartssonAJohansenHKHaahrMTAltmanDG

2007

Ghost authorship in industry-initiated randomised trials.

PLoS Med

4

e19

doi:10.1371/journal.pmed.0040019

6. RossJSHillKPEgilmanDSKrumholzHM

2008

Guest authorship and ghostwriting in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation.

JAMA

299

1800

1812

7. Danish Ministry of Science, Technology and Innovation

2005

Bekendtgørelse om udvalgene vedrørende videnskabelig uredelighed.

Available: https://www.retsinformation.dk/Forms/R0710.aspx?id=29238. Accessed 29 December 2008

8. RennieDYankVEmanuelL

1997

When authorship fails: A proposal to make contributors accountable.

JAMA

278

579

585

9. WagerEFieldEAGrossmanL

2003

Good publication practice for pharmaceutical companies.

Curr Med Res Opin

19

149

154

Available: http://www.gpp-guidelines.org/. Accessed 29 December 2008

10. International Committee of Medical Journal Editors

2008

Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication.

Available: http://www.icmje.org/. Accessed 29 December 2008

11. WagerE

2007

Authors, ghosts, damned lies, and statisticians.

PLoS Med

4

e34

doi:10.1371/journal.pmed.0040034

12. SmithR

2005

Medical journals are an extension of the marketing arm of pharmaceutical companies.

PLoS Med

2

e138

doi:10.1371/journal.pmed.0020138

13. SmithRRobertsI

2006

Patient safety requires a new way to publish clinical trials.

PLOS Clin Trial

1

e6

doi:10.1371/journal.pctr.0010006

14. FlanaginACareyLAFontanarosaPBPhillipsSGPaceBP

1998

Prevalence of articles with ghost authors and ghost authors in peer-reviewed medical journals.

JAMA

280

222

224

15. MowattGShirranLGrinshawJMRennieDFlanaginA

2002

Prevalence of honorary and ghost authorship in Cochrane reviews.

JAMA

287

2769

2771

16. WoolleyKLElyJAWoolleyMJFindlayLLynchFA

2006

Declaration of medical writing assistance in international peer-reviewed publications.

JAMA

296

932

934

17. MartinsonBCAndersonMSdeVriesR

2005

Scientists behaving badly.

Nature

435

737

738

18. WoolleyKL

2006

Goodbye ghostwriters!: How to work ethically and efficiently with professional medical writers.

Chest

130

921

923

19. Griffin-SobelJP

2005

The status of peer review.

Clin J Oncol Nurs

9

669

20. SchererRWLangenbergPvon ElmE

2007

Full publication of results initially presented in abstracts.

Cochrane Database Syst Rev

MR000005

21. NorrisRBowmanAFaganJMGallagherERGeraciAB

2007

International Society for Medical Publication Professionals (ISMPP) position statement: The role of the professional medical writer.

Curr Med Res Opin

23

1837

1840

22. RisingKBacchettiPBeroL

2008

Reporting bias in drug trials submitted to the Food and Drug Administration: Review of publication and presentation.

PLoS Med

5

e217

doi:10.1371/journal.pmed.0050217

23. HamiltonCWRoyerMG

2003

AMWA position statement on the contributions of medical writers to scientific publications.

AMWA J

18

13

15

24. JacobsAWagerE

2005

European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.

Curr Med Res Opin

21

317

322

25. Pharmaceutical Research and Manufacturers of America

2004

Principles on conduct of clinical trials and communication of clinical trial results.

Available: http://www.phrma.org/files/Clinical%20Trials.pdf. Accessed 29 December 2008